β-lactam-induced OMV release promotes polymyxin tolerance in Salmonella enterica sv. Typhi
Frontiers in Microbiology · 25.03.2024 · 15
DOI: 10.3389/fmicb.2024.1389663 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 25.03.2024. Verfasst von Pedro Marchant und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Genética y Patogénesis Bacteriana, Departamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andres Bello, San…. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The rise of multidrug-resistant bacteria is a global concern, leading to a renewed reliance on older antibiotics like polymyxins as a last resort. Polymyxins, cationic cyclic peptides synthesized nonribosomally, feature a hydrophobic acyl tail and positively charged residues. Their antimicrobial mechanism involves initial interaction with Gram-negative bacterial outer-membrane components through polar and hydrophobic interactions. Outer membrane vesicles (OMVs), nano-sized proteoliposomes secreted from the outer membrane of Gram-negative bacteria, play a crucial role in tolerating harmful molecules, including cationic peptides such as polymyxins. Existing literature has documented environmental changes’ impact on modulating OMV properties in Salmonella Typhimurium. However, less information exists regarding OMV production and characteristics in Salmonella Typhi. A previous study in our laboratory showed that S. Typhi Δ mrcB , a mutant associated with penicillin-binding protein (PBP, a β-lactam antibiotic target), exhibited hypervesiculation. Consequently, this study investigated the potential impact of β-lactam antibiotics on promoting polymyxin tolerance via OMVs in S. Typhi. Our results demonstrated that sub-lethal doses of β-lactams increased bacterial survival against polymyxin B in S. Typhi. This phenomenon stems from β-lactam antibiotics inducing hypervesiculation of OMVs with higher affinity for polymyxin B, capturing and diminishing its biologically effective concentration. These findings suggest that β-lactam antibiotic use may inadvertently contribute to decreased polymyxin effectivity against S. Typhi or other Gram-negative bacteria, complicating the effective treatment of infections caused by these pathogens. This study emphasizes the importance of evaluating the influence of β-lactam antibiotics on the interaction between OMVs and other antimicrobial agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratorio de Genética y Patogénesis Bacteriana, Departamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile.
- Escuela de Tecnología Médica, Facultad de Salud, Universidad Santo Tomás, Santiago, Chile.
- Escuela de Química y Farmacia, Facultad de Medicina, Universidad Andres Bello, Santiago, Chile.
- Laboratorio de RNAs Bacterianos, Departamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile.
- Microbiota-Host Interactions and Clostridia Research Group, Universidad Andres Bello, Santiago, Chile.
Zitieren
APA
Marchant, P., Vivanco, E., Silva, A., Nevermann, J., Fuentes, I., Barrera, B., Otero, C., Calderón, I. L., Gil, F., & Fuentes, J. A. (2024). β-lactam-induced OMV release promotes polymyxin tolerance in Salmonella enterica sv. Typhi. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1389663
Vancouver
Marchant P, Vivanco E, Silva A, Nevermann J, Fuentes I, Barrera B, et al. β-lactam-induced OMV release promotes polymyxin tolerance in Salmonella enterica sv. Typhi. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1389663
BibTeX
@article{Marchant2024,
author = {Marchant, Pedro and Vivanco, Erika and Silva, Andrés and Nevermann, Jan and Fuentes, Ignacio and Barrera, Boris and Otero, Carolina and Calderón, Iván L and Gil, Fernando and Fuentes, Juan A},
title = {β-lactam-induced OMV release promotes polymyxin tolerance in Salmonella enterica sv. Typhi},
journal = {Frontiers in Microbiology},
year = {2024},
volume = {15},
doi = {10.3389/fmicb.2024.1389663}
}
EUVIMED